Description
For a concise, image-heavy guide to making accurate diagnoses from a range of cytopathology specimens, choose
Differential Diagnoses in Surgical Pathology: Cytopathology, the latest addition to the renowned series.
Compare similar entities—or those with many common attributes—and learn to spot the elements and details that can
impact diagnosis. Like other volumes in the series the book presents material in a way that pathologists actually
work, and is ideal as a quick-reference guide or for deep-dive research.
Chapter 1 Gynecologic Cytopathology
1.1 Low-Grade Squamous Intraepithelial Lesion (LSIL) Versus High-Grade Squamous Intraepithelial Lesion (HSIL)
1.2 High-Grade Squamous Intraepithelial Lesion (HSIL) Versus Squamous Cell Carcinoma
1.3 High-Grade Squamous Intraepithelial Lesion (HSIL) Versus Endocervical Adenocarcinoma
1.4 Squamous Cell Carcinoma Versus Endocervical Adenocarcinoma
더보기
1.5 High-Grade Squamous Intraepithelial Lesion (HSIL) Versus Adenocarcinoma In Situ (AIS)
1.6 High-Grade Squamous Intraepithelial Lesion (HSIL) Versus Squamous Metaplasia
1.7 Glycogenated Cells Versus Low-Grade Squamous Intraepithelial Lesion (LSIL) (koilocytes)
1.8 Benign Endometrial Cells Versus Endometrial Adenocarcinoma
1.9 Endometrial Adenocarcinoma Versus Metastatic Adenocarcinoma
1.10 Adenocarcinoma In Situ (AIS) Versus Endocervical Adenocarcinoma
1.11 Endocervical Adenocarcinoma Versus Endometrial Adenocarcinoma
1.12 Intrauterine Device (IUD) Changes Versus Endometrial Adenocarcinoma
1.13 Reparative Change Versus High-Grade Squamous Intraepithelial Lesion (SIL)
1.14 Tubal Metaplasia Versus High-Grade Squamous Intraepithelial Lesion (HSIL)
1.15 Benign Endometrial Cells Versus High-Grade Squamous Intraepithelial Lesion (HSIL)
1.16 Adenocarcinoma In Situ (AIS) Versus Benign Endometrial Cells
1.17 Trichomonas Changes Versus Low-Grade Squamous Intraepithelial Lesion (LSIL)
1.18 High-Grade Squamous Intraepithelial Lesion (HSIL) Versus Atrophy
1.19 Small Cell Carcinoma Versus Follicular Cervicitis
Chapter 2 Pulmonary
2.1 Benign Bronchial Respiratory Epithelium (BRE) Versus Well-Differentiated Adenocarcinoma
2.2 Carcinoid Tumor Versus Well-Differentiated Adenocarcinoma
2.3 Carcinoid Tumor Versus Small-Cell Carcinoma
2.4 Small-Cell Carcinoma Versus Reserve Cell Hyperplasia
더보기
2.5 Large-Cell Neuroendocrine Carcinoma Versus Small-Cell Carcinoma
2.6 Adenocarcinoma Versus Squamous Cell Carcinoma
2.7 Mesothelioma Versus Squamous Cell Carcinoma
2.8 Mesothelioma Versus Adenocarcinoma
2.9 Granuloma Versus Neoplasm
2.10 Non-Hodgkin Lymphoma Versus Small-Cell Carcinoma
2.11 Goblet Cell Hyperplasia Versus Adenocarcinoma
2.12 Pneumocyte Hyperplasia Versus Adenocarcinoma
2.13 Postpneumonia Changes Versus Adenocarcinoma
2.14 Squamous Metaplasia Versus Squamous Cell Carcinoma
2.15 Pulmonary Alveolar Proteinosis Versus Pneumocystis jirovecii Infection
Chapter 3 Urinary Tract
3.1 Degenerative Atypia Versus Degenerated High-Grade Urothelial Carcinoma
3.2 Renal Tubular Cells Versus High-Grade Urothelial Carcinoma
3.3 Umbrella Cells Versus Degenerated High-Grade Urothelial Carcinoma
3.4 Low-Grade Urothelial Neoplasia Versus Benign Urothelial Tissue Fragments
더보기
3.5 High-Grade Urothelial Carcinoma Versus Low-Grade Urothelial Neoplasia
3.6 Prostate Adenocarcinoma Versus High-Grade Urothelial Carcinoma
3.7 Squamous Cell Carcinoma Versus Degenerated High-Grade Urothelial Carcinoma
3.8 Small-Cell Carcinoma Versus Inflammation
3.9 Stone Atypia Versus Degenerated High-Grade Urothelial Carcinoma
3.10 Polyoma (BK) Virus Versus High-Grade Urothelial Carcinoma
Chapter 4 Thyroid
4.1 Medullary Thyroid Carcinoma (MTC) Versus Hurthle Cell Neoplasm (HCN)
4.2 Hurthle Cell Neoplasm (HCN) Versus Oncocytic Papillary Thyroid Carcinoma (PTC)
4.3 Hashimoto Thyroiditis Versus Papillary Thyroid Carcinoma (PTC)
4.4 Parathyroid Tissue Versus Adenomatoid Nodule
더보기
4.5 Medullary Thyroid Carcinoma (MTC) Versus Parathyroid Tissue
4.6 Cellular Adenomatoid Nodule Versus Suspicious for a Follicular Neoplasm (SFN)
4.7 Cystic Papillary Thyroid Carcinoma (PTC) Versus Benign Cystic Degeneration
4.8 Colloid Nodule Versus Cyst Fluid
4.9 Papillary Thyroid Carcinoma (PTC) Versus Medullary Thyroid Carcinoma (MTC)
4.10 Papillary Thyroid Carcinoma (PTC) Versus Suspicious for a Follicular Neoplasm (SFN)
4.11 Papillary Thyroid Carcinoma (PTC) Versus Cellular Adenomatoid Nodule
4.12 Cyst-Lining Cells Versus Cystic Papillary Thyroid Carcinoma (PTC)
4.13 Noninvasive Follicular Thyroid Neoplasm With Papillary-like Nuclear Features (NIFTP) Versus Papillary Thyroid
Carcinoma (PTC), Follicular Variant
4.14 Anaplastic Thyroid Carcinoma Versus Metastatic Cancers
4.15 Insular Thyroid Carcinoma Versus Papillary Thyroid Carcinoma (PTC)
4.16 Hyalinizing Trabecular Adenoma Versus Papillary Thyroid Carcinoma (PTC)
4.17 Graves' Disease Versus Papillary Thyroid Carcinoma (PTC)
4.18 Hyalinizing Trabecular Adenoma (HTA) Versus Medullary Thyroid Carcinoma (MTC)
Chapter 5 Pancreas
5.1 Benign Pancreatic Acinar Tissue Versus Acinar Cell Carcinoma
5.2 Pancreatic Neuroendocrine Tumor (PanNET) Versus Well-Differentiated Adenocarcinoma (ACA)
5.3 Well-Differentiated Adenocarcinoma (ACA) Versus Benign Ductal Tissue
5.4 Pancreatic Neuroendocrine Tumor (PanNET) Versus Solid Pseudopapillary Neoplasm (SPN)
더보기
5.5 Pancreatic Neuroendocrine Tumor (PanNET) Versus Acinar Cell Carcinoma
5.6 Solid Pseudopapillary Neoplasm (SPN) Versus Acinar Cell Carcinoma
5.7 Chronic Pancreatitis Versus Well-Differentiated Adenocarcinoma
5.8 Adenocarcinoma (ACA) Versus Metastatic Renal Cell Carcinoma (RCC)
5.9 Mucin-Producing Neoplastic Cyst Versus Gastrointestinal Contamination
5.10 Pseudocyst Versus Lymphoepithelial Cyst (LEC)
5.11 Pancreatic Neuroendocrine Tumor (PanNET) Versus Accessory Spleen (Splenule)
5.12 Gastrointestinal Contamination Versus Adenocarcinoma (ACA)
Chapter 6 Serous Effusions
6.1 Reactive Mesothelial Cells Versus Adenocarcinoma
6.2 Metastatic Adenocarcinoma Versus Endosalpingiosis
6.3 Mesothelial Hyperplasia Versus Mesothelioma
더보기
6.4 Metastatic Adenocarcinoma Versus Mesothelioma
6.5 Non-Hodgkin Lymphoma Versus Lymphocytosis
Chapter 7 Cerebrospinal Fluid (CSF)
7.1 Metastatic Carcinoma Versus Macrophages
7.2 Lymphoma Versus Pleocytosis
7.3 Hematopoiesis Versus Leukemia
7.4 Metastatic Carcinoma Versus Lymphoma
Chapter 8 Salivary Gland
8.1 Adenoid Cystic Carcinoma Versus Pleomorphic Adenoma
8.2 Mucocele Versus Mucoepidermoid Carcinoma
8.3 Warthin Tumor Versus Oncocytoma
더보기
8.4 Benign Acini Versus Acinic Cell Carcinoma
8.5 Acinic Cell Carcinoma Versus Oncocytoma
Chapter 9 Kidney
9.1 Oncocytic Neoplasm Versus Benign Renal Tubular Cells
9.2 Papillary Renal Cell Carcinoma Versus Glomerulus
9.3 Angiomyolipoma Versus Papillary Renal Cell Carcinoma
더보기
9.4 High Grade Urothelial Carcinoma Versus Clear Cell Renal Cell Carcinoma
9.5 Adrenal Tissue Versus Clear Cell Renal Cell Carcinoma
Chapter 10 Soft Tissue
10.1 Schwannoma Versus Gastrointestinal Stromal Tumor
10.2 Leiomyosarcoma Versus Gastrointestinal Stromal Tumor
10.3 Fibromatosis (Desmoid Type) Versus Schwannoma
더보기
10.4 Nodular Fasciitis Versus Malignant Peripheral Nerve Sheath Tumor (MPNST)
10.5 Myxoid Liposarcoma Versus Myxoma
10.6 Malignant Peripheral Nerve Sheath Tumor (MPNST) Versus Spindle Cell Melanoma
10.7 Synovial Sarcoma Versus Adenocarcinoma
10.8 Conventional Chondrosarcoma Versus Chordoma
Chapter 11 Liver
11.1 Benign Hepatocytes Versus Well-Differentiated Hepatocellular Carcinoma
11.2 Cholangiocarcinoma Versus Hepatocellular Carcinoma
11.3 Cholangiocarcinoma Versus Benign Hepatocytes and Ductal Cells
Chapter 12 Breast
12.1 Apocrine Metaplasia Versus Ductal Adenocarcinoma
12.2 Fibroadenoma Versus Ductal Adenocarcinoma
12.3 Papilloma Versus Ductal Adenocarcinoma
더보기
12.4 Papilloma Versus Fibroadenoma
12.5 Mucocele Versus Colloid Carcinoma
Index